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Abstract
Background: Risk stratification methods developed on the basis of predicting illness severity are often used to
prioritise patients on the basis of urgency. Illness severity and urgency may not be interchangeable. Severe illness
places patients at risk of adverse outcome, but treatment is only urgent if adverse outcome can be prevented by
time-sensitive treatment. We aimed to develop a score to identify patients in need of urgent treatment, on the
basis of potential to benefit from time-sensitive intervention, and to compare this with a severity score identifying
patients at high risk of death.
Methods: A sequential cohort of adults presenting to one Emergency Department by ambulance and admitted to
hospital was prospectively collected (2437 derivation, 2322 validation). Data on outcomes representing potential to
benefit was collected retrospectively on a random subset (398 derivation, 227 validation). Logistic regression identified
variables predictive of death and potential to benefit from urgent treatment.
Results: Death was predicted using age, respiratory rate, diastolic blood pressure, oxygen saturations, temperature,
GCS and respiratory disease (AUROC 0.84 (95 % CI 0.8–0.89) derivation and 0.74 (0.69–0.81) validation), while potential
to benefit was predicted by pulse, systolic blood pressure and GCS (AUROC 0.74 (0.67–0.80) derivation and 0.71
(0.59–0.82) validation).
Conclusions: A score developed to predict the need for urgent treatment has a different composition to a score
developed to predict illness severity, suggesting that triage methods based on predicting severity could lead to
inappropriate prioritisation on the intended basis of urgency.
Introduction
Background
There were 5.3 million emergency hospital admissions
in England in 2012–3, mainly from the 21 % of
Emergency Department (ED) attendances resulting in
hospital admission [1]. Similarly, in 2010–11, only
71,801 (45 %) of 160,460 critical care admissions were
planned [2]. EDs and admissions units therefore need
rapid and accurate methods to identify those in ur-
gent need of treatment.
Importance
Within emergency care illness severity and urgency are
often assumed to be interchangeable concepts. However,
severity reflects the risk of a poor outcome or impact of
a condition upon the patient [3], whereas urgency re-
flects the potential to benefit from timely care; so a pa-
tient with metastatic cancer would be severely ill but a
patient with facial angioedema would be of high ur-
gency. A measure of patient urgency should identify pa-
tients whose outcome will be improved with prompt
care and/or those whose outcome will worsen without
this care. We have demonstrated that many risk scores
have been developed to predict adverse outcomes not
amenable to intervention, and are therefore severity ra-
ther than urgency scores [4].
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Recent commentary has drawn attention to the dis-
connect between the identification of patients at risk of
a particular outcome and the potential of those patients
to benefit from available interventions [5]. Although sys-
tems to identify deteriorating patients and responding
rapidly are intuitively appealing [6], meta-analysis of
these amongst in-patients has failed to identify a benefit
in terms of patient outcome [7, 8]. This may reflect use
of scores that measure severity rather than urgency.
Goals
We therefore aimed to develop a score to identify in the
ED patients of high urgency with the potential to benefit
from time-sensitive interventions, and to compare this
with a score to identify patients at high risk of death.
Methods
Study design and setting
This study was developed alongside the DAVROS pro-
ject which developed and validated a risk-adjustment
method for research and audit in emergency care and
has been described in full elsewhere [9]. Data were col-
lected from February-May (derivation) and October-
December (validation) 2008 at Northern General Hospital,
Sheffield, the only adult ED serving the half million popu-
lation of Sheffield. It is an acute teaching hospital with
1100 beds. The ED at the time of the study had 98,000 at-
tendances per year. Interventional cardiology, critical care
and acute theatres are all available on site.
Subjects
Patients were included if they were transported by an
emergency ambulance, then either died in the ambu-
lance or ED or were admitted to hospital. Patients who
had no vital signs at the time of ambulance arrival (even
if resuscitation was attempted) were excluded. Patients
aged under 65 with trauma were excluded prospectively
as risk prediction in the trauma population has been ex-
tensively studied and is strongly influenced by variables
such as injury site and type which are not replicated in
non-trauma patients (see https://www.tarn.ac.uk). Pa-
tients aged over 65 were excluded retrospectively if their
reason for admission was purely for trauma. The cohort
was restricted to patients presenting by ambulance to en-
sure a clear point of entry to the emergency care system.
Children and patients with purely obstetric presentations
were excluded as their physiology is different and therefore
predictors of adverse outcome are likely to be different, as
are mortality and critical illness rates.
The whole dataset was used to develop the tool to pre-
dict death. Patient casenotes were screened in date order
until adequate numbers of patients with outcomes of
interest were included for the tool to predict potential to
benefit. This group constituted the “potential to benefit”
subset of the study population.
Ethical approval
Ethical approval for both studies was obtained from
Leeds (East) REC (09/H1306/2). Approval to use patient
identifiable data without specific consent was gained
from the Patient Information Advisory group for the ori-
ginal study and from the National Information Govern-
ance Board (ECC 5-07(f )/2009) for this study.
Data extraction
Predictor variables were extracted from ED records within
2 days of presentation and entered directly into an online
database. Data entry staff were clerical personnel who
were specifically trained for the study but had no involve-
ment in the analysis phase. Study staff randomly sampled
and rechecked entered data to ensure data quality. Age,
blood pressure, Glasgow coma scale, oxygen saturation
(breathing air and/or breathing supplemental oxygen),
pulse rate, respiratory rate and temperature as recorded
on arrival at the ED were chosen as they are widely re-
corded in a relatively standardised manner. Pulse pressure
was calculated from systolic and diastolic blood pressures
immediately prior to data analysis. Also extracted from
the ED notes was the presence of specific co-morbidities
(active malignancy, chronic respiratory disease, heart dis-
ease, asthma, diabetes, epilepsy, and warfarin or steroid
use), as recorded by the attending clinician. Presenting
complaint was recorded verbatim as described to recep-
tion staff but not further analysed as there was no way of
confirming consistency of recording.
Outcomes
The patient group of interest in this study is those where
urgent intervention had the potential to affect survival,
ie where a patient death was prevented or could poten-
tially have been prevented by urgent intervention. We
therefore classified 7-day outcomes as:
a. inevitable death: the patient died and a decision was
made within 24 h of admission not to attempt CPR;
b. potentially preventable death, where the patient died
but no decision was made to withdraw or limit care;
c. potentially prevented death, where the patient survived
and received a potentially life-saving intervention
(defined below);
d. non-critical illness.
The 7 day timescale was selected to achieve a balance
between allowing sufficient time for an illness course to
declare itself and minimising confounding by chronic dis-
ease and/or iatrogenic factors. Mortality was recorded by
study staff using hospital record review, supplemented by
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a search of Coroner’s Office records. It was assumed that
all patients admitted to intensive care received potentially
life-saving intervention(s) [10, 11]. Interventions that had
the potential to prevent death were identified from hos-
pital casenotes by KC using a priori definitions (Table 1)
based on evidence-based guidelines for acute care
(Appendix). No judgement was made as to whether the
intervention was helpful in individual cases, and outcome
data was abstracted before examination of predictor vari-
able data, to minimise abstractor bias [12]. It must be
noted that many of these interventions are not supported
by high quality evidence. They are, however, similar to the
list of life-saving interventions developed independently
and concurrently by another research group [13]. It was
not possible to examine primary care records to see if pa-
tients were admitted within the 7 days to a different hos-
pital; however given local geography and facilities this was
felt to be unlikely.
Data analysis
Sample size was based on ten observed outcome events
per predictor variable included in the analysis [14].
Given the different frequencies of death and potential to
benefit the sample sizes required for the two outcomes
therefore varied.
Risk of each outcome in various groupings of predictor
variables was explored visually using histograms (data
available). Groups of similar risk were collapsed for fur-
ther analysis. Given the absence of linear and monotonic
relationships with risk, we wished to avoid arbitrary
dichotomisation of data and therefore avoided decision
tree analysis. Univariate association between potential
predictor variables and outcome was assessed using lo-
gistic regression in SPSS, and first order interaction of
variables significant at p < 0.15 was examined. Variables
found to be significantly predictive of outcome at p < 0.1
were block entered into the multivariate analysis. Linear
coefficients were then recalculated for independently
predictive variables and an equation to predict poor out-
come generated from those coefficients using the general
formula p(outcome) = exb/1 + exb, where xb is the linear
predictor.
The equations generated were applied to the validation
sets without re-estimation of coefficients and perform-
ance assessed using ROC curves.
Results
Study subjects
The derivation cohort included 2437 patients (1131
male, mean age 69) with 398 in the potential to benefit
subset (183 male, mean age 66.5), while the validation
cohort included 2322 patients (1093 male, mean age 70)
with 227 in the potential to benefit subset (95 male,
mean age 71.3) (fig 1 for CONSORT diagram). Table 2
compares demographic characteristics of both popula-
tions and subsets.
Statistical analysis
After grouping variables and collapsing groups with
similar risk, variables significantly predictive of potential
to benefit on univariate analysis are in Table 3. Full
Table 1 Interventions defined a priori as potentially life-saving
Airway interventions
• Use of airway adjunct or procedure to maintain patent airway.
• Use of intravenous/intramuscular adrenaline to treat or prevent
airway compromise.
Breathing interventions
• Bag-valve-mask ventilation (unless during procedural sedation),
intermittent positive pressure ventilation, or non-invasive ventilation.
• Decompression of tension pneumothorax.
• Drainage of significant pleural effusion (>1 litre).
• Insertion of chest drain for pneumothorax in patients with pre-existing
lung disease.
• Intravenous therapy except steroids for asthma.
Circulation interventions
• Cardioversion (chemical or DC) of ventricular tachycardia or
supraventricular tachycardia or atrial fibrillation with accessory
pathway.
• CPR.
• Emergency endoscopy or surgery for upper GI bleed or use of
Sengstaken tube or use of vasopressin/terlipressin.
• Infusion of >2 litres of fluid or transfusion for haemodynamic
instability.
• Laparotomy for GI bleed/gynaecological bleed (including ectopic)/
AAA.
• Sepsis care bundle.
• Thrombolysis for AMI or PE, or percutaneous revascularisation.
• Therapeutic (not diagnostic) pericardiocentesis.
• Transcutaneous or external pacing or administration of atropine
(except in theatre).
• Vasopressor use (except bolus dosing in theatre).
Disability interventions
• Administration of naloxone or flumazenil (unless related to procedural
sedation).
• Administration of 10 %/50 % dextrose.




• Active rewarming (not including Bearhugger).
• Laparotomy for sepsis/infarction/obstruction.
• New initiation of renal replacement therapy.
• Specific poisons antidotes including N-acetylcysteine.
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details of all variables assessed are in Additional file 1:
Table S1.
Analysis of interactions showed significant interactions
in: pulse by respiratory rate, systolic blood pressure and
SaO2, respiratory rate by pulse pressure and SaO2, sys-
tolic blood pressure by pulse pressure and SaO2 and
pulse pressure by SaO2. Briefly it appears that hypoxia
confers increased risk if tachycardia is absent or if
tachypnoea is present, and that normal pulse pressure
confers increased risk in the presence of systolic
hypotension.
Multivariate logistic regression analysis including in-
teractions of oxygen saturations with pulse and respira-
tory rate produced estimated odds ratios (Exp(B)) and p
values as in Table 4, with pulse, systolic blood pressure
and GCS remaining significant. These were block re-
Fig. 1 Consort diagram
Table 2 Patient demographics
Derivation cohort Validation cohort
Full cohort for death
(n = 2437)
Subset for potential to benefit
(n = 398)
Full cohort for death
(n = 2322)
Subset for potential to benefit
(n = 227)
Variable Mean (sd; range)
Age 69 (19; 18–103) 66.5 (20.2; 18–102) 70 (19; 18–103) 71.3 (18.3; 19–96)
Respiratory rate 19 (6;6–60) 20 (7; 6–45) 20 (6.6; 8–80) 20 (5.8; 12–40)
Systolic BP 136 (29; 24–266) 133 (29; 45–243) 139 (28.4; 44–261) 138 (28.6; 60–249)
Diastolic BP 75 (15; 30–153) 75 (15; 36–130) 76 (15; 11–151) 74 (15; 36–142)
Pulse rate 88 (24; 21–215) 92 (24; 35–188) 88 (23; 20–180) 89 (21.9; 35–152)
Temperature 36.6 (1.2; 26.0–41.0) 36.5 (1.2; 26.0–40.0) 36.5 (1.1; 25.2–40.5) 36.6 (1.40; 26.4–39.6)
Variable Median (IQR; range)
SaO2 breathing air 97 (95–98; 50–100) 97 (94–98; 66–100) 97 (95–98; 45–100) 96 (94–98; 45–100)
SaO2 breathing oxygen 98 (95–100; 24–100) 97 (96–99; 71–100) 98 (95–100; 60–100) 98 (96–100; 84–100)
GCS 15 (15–15; 3–15) 15 (15–15; 3–15) 15 (15–15; 3–15) 15 (15–15; 7–15)
Variable Number (percentage)
Male 1131 (46.4) 183 (46) 1093 (46.5) 95 (42)
Active malignancy 110 (4.5) 23 (5.8) 96 (4.1) 6 (2.7)
Outcomes Number (percentage)
All deaths 128 (5.2) 141 (6.0)
Inevitable death 15 (3.7) 2 (0.8)
Potentially preventable death 5 (1.2) 1 (0.4)
Prevented death 79 (19.8) 35 (15.4)
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entered into a multivariate analysis to develop linear co-
efficients for the final model:
P potential to benefitð Þ ¼ exb=1þ exb
where xb = (pulse[71–110]*2.373) + (pulse[>110]*9.533) +
(sbp[<100]*3.614) + (sbp[100-120]*1.488) + (sbp[>180]*
2.888) + (gcs[3-8]*13.28) + (gcs[9-12]*2.770).
The performance of this equation was assessed using a
ROC curve, which had an area under the curve (c-statistic)
of 0.737 (95 % CI 0.671–0.804). When applied to the valid-
ation set it had an area under the curve (c-statistic) of
0.707 (95 % CI 0.594–0.820).
The same process when performed to predict all deaths
at 7 days (multivariate analysis in Additional file 1: Table
S2, full details available) generated the equation below. Of
note is the inclusion of age, temperature and co-morbidity
which predict death but not potential to benefit.
P deathð Þ ¼ exb=1þ exb
where xb = (age[50–69]*0.608) + (age[70–85]*0.348) +
(age[>85]*0.924) + (respiratory rate[19-23]*1.753) +
(respiratory rate[>23]*2.791) + (DBP[<65]*3.172) +
(DBP[>90]*5.204) + (sao2[high risk]*3.202) + (sao2[moderate
risk]*0.932) + (temperature[<36]*4.714) + (GCS[3-12]*
29.372) + (GCS[13-14]*5.311) + (respiratory disease
[present]*12.355) + (respiratory disease [present] and
temperature[<36]*7.466).
This had a c-statistic of 0.847 (95 % CI 0.8–0.894).
When applied to the validation set, the equation had an
area under the curve (c-statistic) of 0.741 (95 % CI
0.685–0.806).
Discussion
We have demonstrated that a combination of pulse, sys-
tolic blood pressure and Glasgow Coma Score can predict
provision of time-sensitive interventions with moderate
discrimination. Different variables (age, respiratory rate,
diastolic blood pressure, oxygen saturations, temperature,
Glasgow Coma Score and a pre-existing diagnosis of re-
spiratory disease) predict death within seven days. Thus a
score developed to predict the need for urgent treatment
will differ from a score developed to predict illness sever-
ity, suggesting that triage methods based on severity could
lead to inappropriate prioritisation on the intended basis
of urgency.
Table 3 Univariate logistic regression analysis of predictor
variables for potential to benefit
Variable exp(B) P 95 % CI
for exp(B)
Pulse (ref <71) <0.001
71–110 0.522 0.316 0.862
>110 3.756 1.930 7.309
Respiratory rate (ref <16) <0.001
16–18 1.009 0.605 1.683
19–23 3.463 1.819 6.594
>23 3.991 2.140 7.443
Systolic BP (ref 121–180) <0.001
<100 4.461 2.397 8.302
100–120 2.140 1.250 3.665
>180 31.475 13.479 73.496
Pulse pressure (ref 51–76) <0.001
<51 1.791 1.143 2.805
>76 3.540 2.030 6.174
GCS (ref 13–15) <0.001
3–8 34.446 16.607 71.447
9–12 2.203 1.235 3.930
SaO2 (ref low risk (99–100
breathing air))
<0.001
High (<95 breathing air or <96
with supplemental O2)
1.583 0.156 0.839 2.987
Moderate (95–98 breathing air
or >95 with supplemental O2)
0.470 0.004 0.283 0.781
Table 4 Multivariate analysis of predictor variables for potential
to benefit
Variable exp(B) p 95 % CI for exp(B)
Pulse (ref <71) 0.02
71–110 0.371 0.034 4.101
>110 5.176 1.125 23.816
Respiratory rate (ref <16) 0.228
16–18 4.814 0.636 36.443
19–23 19.144 1.035 354.172
>23 6.664 0.723 61.405
Systolic BP (ref 121–180) 0.061
<100 3.687 1.089 12.481
100–120 1.112 0.407 3.043
>180 2.468 0.615 9.905
Pulse pressure (ref 51–76) 0.536
<51 1.479 0.548 3.992
>76 1.729 0.611 4.894
GCS (ref 13–15) <0.001
3–8 23.013 3.806 139.163
9–12 4.060 1.114 14.790
SaO2 (ref low risk) 0.971
High 0.946 0.146 6.123
Moderate 0.840 0.164 4.300
Pulse/SaO2 interaction 0.210
Respiratory rate/SaO2 interaction 0.210
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Strengths
This is the first study specifically to address the identifi-
cation of at-risk patients in an ED population not prese-
lected for diagnosis or severity, and to use the provision
of a life-saving intervention as an outcome measure. It
therefore addresses the issues facing emergency clini-
cians more closely than the existing literature.
Although our definitions of time-sensitive interven-
tions might be criticized for being defined arbitrarily, the
concept of an “Emergency Care Sensitive Condition” is
being more widely embraced and supports our method-
ology [15]. It is apparent that patterns of physiological
derangement differ between patients who die and those
who receive life-saving intervention [16]. The develop-
ment of a tool to identify this second group was there-
fore necessary.
Limitations
Patients who were not admitted to hospital and those
who self-presented were excluded from the initial study
dataset as the aim was to develop a risk-adjustment tool
for emergency admissions to hospital. This limits the
generalisability of this study in terms of developing a
clinical score. Ideally a full cohort of presenting patients
would be studied and those discharged from the ED
followed up to analyse post-discharge adverse events.
However that is logistically unfeasible, as rates of short-
term death after discharge from the ED are 30–50/
100,000 [17, 18], and only 11 % of self-presenting pa-
tients are admitted to hospital [1], so the required cohort
size would have been impractical. Obviously our findings
cannot be applied to other patient groups such as chil-
dren or trauma patients.
Our definition of an inevitable death might be consid-
ered overly restrictive but we chose this deliberately to
include the widest possible group as having potential to
benefit.
As a single-site study it may be that these results are
not generalisable; interpretation of vital sign derange-
ment is not only affected by patient factors but also by
the health care system, staffing levels and types and time
available for patient care [19]. Thus a process of external
validation might find that life-saving interventions are
provided differently in other settings.
We initially wished to examine the role of clinician ge-
stalt in detection of the at-risk patient. Early data collec-
tion included a “yes/no” question to the transporting
paramedic as to whether the patient was critically ill; this
had to be abandoned due to poor rates of completion.
Implications for clinical practice and policy
The variables we have identified as predictive of a need
for life-saving intervention are not the same as those in
use in many standardized early warning scores. This
may reflect the inappropriateness of developing early
warning scores using data sets in which death is the
main outcome. This score may be more appropriate than
existing scores but should not yet be widely applied in
standard practice. It needs wider validation, ideally in-
cluding comparison with unstructured clinician (doctor
or triage nurse) gestalt and with NEWS as the currently
mandated standard of care. There must also be consider-
ation as the score is applied of whether the outcomes
used to develop definitions of urgency are still valid; the
interventions listed in the Appendix are acknowledged
to be based on incomplete evidence; it is to be hoped
that as the evidence base for emergency care is devel-
oped these can be refined (for example, intravenous
magnesium in acute severe asthma would no longer be
considered a potentially life-saving intervention [20]).
These results highlight the potential flaws in applying
clinical scores to predict outcomes other than those for
which they were originally derived. As the health econo-
mist Tony Culyer said “capacity to benefit is not identi-
cal to need” [21], and clinicians should be clear about
the reasons for which a score is being used. Equally, if a
scoring system is used as casemix adjustment in an at-
tempt to assess or improve quality, it should be clear
that it identifies conditions which are amenable to alter-
ation with good care [15].
This leaves the working emergency clinician in the
situation of not having a score developed for and dem-
onstrated to work in the emergency setting. There are
two options: firstly to use an existing score but to recog-
nise its limitations in the ED; secondly not to use a score
but to rely on the unstructured judgement of clinical
staff. In the current culture of high regard for standar-
dised paperwork easily amenable to retrospective audit
this is unlikely to be managerially palatable. Given the
current state of equipoise over the utility of standardised
scores in terms of patient benefit clinicians should also
be encouraged to participate in formal research to ad-
dress the issue.
Implications for research
Researchers in other settings have demonstrated the
value of changes in physiological scores in prognostica-
tion [22]; ideally ongoing research would examine the
prognostic value of response (or non-response) to treat-
ment provided prehospitally or in the ED.
We have defined a priori a group of interventions
which appear on best available evidence to be potentially
life-saving and time-sensitive. However, the evidence
supporting these is incomplete and our beliefs under-
lying many frequently-used interventions would bear
further scrutiny; patients who could benefit could then
be more reliably identified. We made no attempt to as-
sess functional outcome of those patients defined as
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having potential to benefit; future researchers may wish
to consider whether morbidity should also be a compo-
nent of benefit.
Identification of and response to the patient at risk re-
quires more than a reliable scoring system; complex psy-
chosocial and cognitive factors affect decision-making,
particularly in the pressured ED environment [23], and
examination of the interaction of these factors should be
a priority for future research [24].
In summary, we have developed a score that predicts
urgency (potential to benefit from time-sensitive treat-
ment) with moderate discrimination. The score has dif-
ferent constituent variables and weights than a score
developed to measure severity (risk of death). Early
warning scores developed to predict death may not be
useful predictors of urgency.
Appendix
Acute care guidelines used to identify potentially
lifesaving interventions
 Acute illness: NICE clinical guideline 50
 Acute onset atrial fibrillation: NICE clinical
guideline 36, SIGN 94 and 129
 Alcohol-related disease: NICE clinical guideline 100
 Anaphylaxis: College of Emergency Medicine
 Arrhythmia: SIGN 94
 Asthma: SIGN 101
 Cardiac arrest: SIGN 94
 COPD: NICE clinical guideline 101
 DVT: NICE clinical guideline 144 and SIGN 122
 Headache: College of Emergency Medicine and
American College of Emergency Physicians
 Hypertension: American College of Emergency
Physicians
 LVF: American College of Emergency Physicians
and European Society of Cardiology
 NSTEMI/Unstable angina: NICE clinical guideline 94,
SIGN 93, American College of Emergency Physicians
and European Society of Cardiology
 PE: NICE clinical guideline 144, SIGN 122,
American College of Emergency Physicians and
European Society of Cardiology
 Pneumonia: American College of Emergency
Physicians and British Thoracic Society
 Pneumothorax (spontaneous): British Thoracic
Society
 Poisoning: NICE clinical guideline 16, American
College of Emergency Physicians and College
of Emergency Medicine
 Seizure: American College of Emergency Physicians
and College of Emergency Medicine
 Sepsis: NICE clinical guideline 151
 STEMI: SIGN 93 and European Society of
Cardiology
 Stroke/TIA: NICE clinical guideline 68, SIGN 108.
 Transient loss of consciousness: NICE clinical
guideline 109
 Type 1 diabetes: NICE clinical guideline 15.
 Upper GI bleeding: NICE clinical guideline 141,
SIGN 105
 Urinary tract infection: SIGN 88
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Additional file 1: Development and validation of a score to identify
patients who may benefit from a time-critical intervention in the
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